Assay.Works
Assay.Works GmbH is a contract research organization dedicated to accelerating drug discovery through the development and execution of predictive, scalable, and quantitative assays. With a legacy of extensive experience in high-throughput screening and assay development, the company offers a broad spectrum of services including assay development, high-throughput screening campaigns, hit identification, lead optimization, and bioactivity assessment. Their mission is to turn challenging assays into reproducible results by combining scientific rigor with expertise in laboratory automation, informatics, and industry best practices. They serve pharmaceutical, biotech, and academic partners, providing tailored solutions across various therapeutic areas.
Industries
Nr. of Employees
small (1-50)
Products
Modular small-molecule screening library (150,000 compounds)
A modular screening collection assembled for lead-likeness and diversity, available as non-redundant sets and customizable decks with analytical verification at admission.
Tiered siRNA screening libraries
Three coverage tiers of siRNA libraries targeting the extended human druggable genome, with varying RNAs-per-gene to balance cost and hit-confidence.
Assay-ready frozen cells and engineered cell line collection
Assay-ready frozen cells produced in large batches and a curated collection of engineered cell lines covering major transmembrane target classes for immediate use in screening and profiling.
Modular small-molecule screening library (150,000 compounds)
A modular screening collection assembled for lead-likeness and diversity, available as non-redundant sets and customizable decks with analytical verification at admission.
Tiered siRNA screening libraries
Three coverage tiers of siRNA libraries targeting the extended human druggable genome, with varying RNAs-per-gene to balance cost and hit-confidence.
Assay-ready frozen cells and engineered cell line collection
Assay-ready frozen cells produced in large batches and a curated collection of engineered cell lines covering major transmembrane target classes for immediate use in screening and profiling.
Services
Custom design, optimization and scale-up of biochemical and cell-based assays for screening and profiling across therapeutic areas.
Automated primary screening, hit confirmation, concentration-response testing, counter-screening and QC for libraries ranging from thousands to millions of compounds.
Automated high-content image acquisition and multi-parametric analysis for phenotypic screening, 3D cultures and live-cell assays with ML-based phenotypic classification.
Assay development, optimization and screening using solid-supported membrane electrophysiology on parallel-well platforms for electrogenic transporters and ion pumps.
Custom expression construct design, high-throughput clone selection, bulk cell production, assay-ready frozen cells, and cell banking with QC and LIMS tracking.
Compound selection, plate production, high-throughput analysis, multi-format plating and worldwide fulfillment with LIMS-based traceability and storage options.
Custom design, optimization and scale-up of biochemical and cell-based assays for screening and profiling across therapeutic areas.
Automated primary screening, hit confirmation, concentration-response testing, counter-screening and QC for libraries ranging from thousands to millions of compounds.
Automated high-content image acquisition and multi-parametric analysis for phenotypic screening, 3D cultures and live-cell assays with ML-based phenotypic classification.
Assay development, optimization and screening using solid-supported membrane electrophysiology on parallel-well platforms for electrogenic transporters and ion pumps.
Custom expression construct design, high-throughput clone selection, bulk cell production, assay-ready frozen cells, and cell banking with QC and LIMS tracking.
Compound selection, plate production, high-throughput analysis, multi-format plating and worldwide fulfillment with LIMS-based traceability and storage options.
Expertise Areas
- Assay development and optimization
- High-throughput screening (HTS) execution
- High-content imaging and phenotypic screening
- Cell engineering and cell line development
Key Technologies
- Automated high-throughput screening platforms
- Automated confocal/high-content microscopy
- Acoustic nanoliter dispensing
- Robotic liquid handling and scheduled automation
News & Updates
Assay.Works will participate in the Bio International Convention in Boston, discussing biotech innovations and showcasing their capabilities.
Participation in the SLAS Europe Conference & Exhibition in Hamburg, focusing on assay development, high-throughput screening, and drug discovery.
Join the Swiss Biotech Day in Basel, connecting with the biotech community and showcasing assay solutions.
Sanjee Tawde, Director of Sales and Business Development, will attend BIOEUROPE Spring 2025 representing Assay.Works.
Sanjee Tawde will attend the conference focusing on drug discovery and the role of AI and machine learning.
Assay.Works will participate in the Bio International Convention in Boston, discussing biotech innovations and showcasing their capabilities.
Participation in the SLAS Europe Conference & Exhibition in Hamburg, focusing on assay development, high-throughput screening, and drug discovery.
Join the Swiss Biotech Day in Basel, connecting with the biotech community and showcasing assay solutions.
Sanjee Tawde, Director of Sales and Business Development, will attend BIOEUROPE Spring 2025 representing Assay.Works.
Sanjee Tawde will attend the conference focusing on drug discovery and the role of AI and machine learning.